Euphon

Euphon lean 300m1

Euphon Lean 300m1 is a cough suppressant. It is recommended for soothing dry or tickling coughs. Codeine (Euphon Syrup) is used to treat mild to moderately severe pain. In a meta-analysis of trials evaluating the treatment of chronic cough. The use of Codeine (Euphon-Syrup) demonstrated efficacy in patients with this condition.
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals. Initiate the dosing regimen for each patient individually, taking into account the patient’s severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse. Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy and following dosage increases with Euphon Syrup (Codeine) Sulfate Tablets, and adjust the dosage accordingly.

Side Effects of Euphon Codeine Syrup

The following serious adverse reactions are described, or described in greater detail, in other sections:
• Addiction, Abuse, and Misuse
• Life-Threatening Respiratory Depression

• Ultra-Rapid Metabolism of Euphon Syrup (Codeine) and Other Risk Factors for Life-Threatening Respiratory Depression in Children

• Neonatal Opioid Withdrawal Syndrome

• Interactions with Benzodiazepines and Other CNS Depressants

• Adrenal Insufficiency

• Severe Hypotension

• Gastrointestinal Adverse Reactions

• Seizures

The following adverse reactions associated with the use of Euphon Syrup (Codeine) were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Serious adverse reactions associated with Euphon Syrup (Codeine) were respiratory depression and, to a lesser degree, circulatory depression, respiratory arrest, shock, and cardiac arrest.